Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

Emily  F. Calderbank; Laura Magnani; Elisa Laurenti

doi:10.3791/66315

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice

免疫不全マウスへのヒト造血幹細胞および前駆細胞の大腿内注射

Full Text

1,873 Views

03:40 min

December 8, 2023

DOI: 10.3791/66315-v

Emily F. Calderbank¹, Laura Magnani¹, Elisa Laurenti¹

¹Wellcome and Medical Research Council Cambridge Stem Cell Institute, Department of Haematology,University of Cambridge

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study investigates the dynamics of hematopoietic stem and progenitor cells (HSPCs) across human development, utilizing intrafemoral injection in immunodeficient mice to enhance cell engraftment. By placing HSPCs directly into the bone marrow, the research aims to improve our understanding of normal blood cell development and the influence of age and disease.

Key Study Components

Research Area

Stem cell biology
Human hematopoiesis
Disease modeling

Background

Healthy human hematopoiesis is studied from fetal stages to elderly.
Understanding the healthy context aids in deciphering disease mechanisms.
Transplantation experiments provide functional insights into stem cell behavior.

Methods Used

Intrafemoral injection of human HSPCs
Immunodeficient mouse model
Cell culturing and preparation techniques

Main Results

Direct injection leads to higher stem cell engraftment.
Provides a quantitative perspective on aging and stem cell function.
Highlights the impact of external factors like inflammation on stem cells.

Conclusions

The study demonstrates effective methods for HSPC engraftment.
Offers insights into blood stem cell evolution and disease predisposition.

Frequently Asked Questions

What is the significance of HSPCs in blood formation?

HSPCs are essential for the formation of all types of blood cells throughout an individual's life.

Why use intrafemoral injections?

This method bypasses the homing phase, allowing for better engraftment of stem cells directly into the bone marrow.

What are the implications of this research for aging?

Understanding how HSPCs function over time can help identify how age-related diseases develop.

How does inflammation affect HSPCs?

Inflammation can alter the function and behavior of HSPCs, potentially leading to diseases.

What are the expected outcomes of the intrafemoral injection?

Higher engraftment rates and more reliable data on HSPC function compared to traditional methods.

Can this method be applied to other cell types?

While primarily used for HSPCs, similar techniques could potentially be adapted for other cell types.

What future research directions does this work suggest?

Future studies could explore the effects of various conditions on HSPC function and health across different age groups.

大腿骨内注射は、少数の造血幹細胞および前駆細胞(HSPC)を骨髄腔に直接配置することにより、生着を可能にします。ここでは、免疫不全マウスへのヒトHSPCの大腿内注射の実験プロトコルについて説明します。

私たちの関心は、胎児から高齢者までの生涯にわたる健康なヒト造血を研究することです。例えば、胎児の肝臓や成人の骨髄や末梢血などを研究しています。私たちは、病気で何が問題になるのかを理解するために、健康的な状況を研究することが重要だと考えています。

近年、この分野を進歩させたシングルセルのOnyxアプローチは数多くありますが、これらは幹細胞の機能をテストする移植実験に取って代わるのではなく、並行して機能します。血液幹細胞と前駆細胞を直接大腿骨に注入することにより、静脈注射のホーミング段階を回避します。細胞はすでに自然環境にあるため、生着がはるかに高いことがよくあります。

View the full transcript and gain access to thousands of scientific videos